Successful options exercise for Spermosens

Lund, May 2022 Spermosens has successfully completed the exercise window of their IPO warrants of series TO 1, with a subscription percentage of 31%, totaling SEK 19,7 million in fresh capital to the Company. The Company is pleased with the exercise, which took place at SEK 12,29 per share, more than double the price of…